BOUT ETF largest holding is ELVN at 7.62% as of Aug 6, 2026
BOUT ETF largest holding is ELVN at 7.62% as of Aug 6, 2026
$44.92
AUM$16M
TER0.80%
Holdings48
See how much of BOUT you already own
BOUT ETF largest holding is ELVN at 7.62% as of Aug 6, 2026
$44.92
CapForce IBD Breakout Opportunities ETF
AUM$16M
TER0.80%
Holdings48
See how much of BOUT you already own
ELVN is BOUT's largest holding at 7.62% of the fund as of Aug 6, 2026. BOUT is CapForce IBD Breakout Opportunities ETF.
BOUT ETF All Holdings
BOUT holdings total 48 positions. The top 10 holdings account for 64.8% of the fund, led by Enliven Therapeutics Inc at 7.6%, Glaukos Corp. at 7.1%, Bicara Therapeutics, Inc. at 7.0%.
BOUT portfolio concentration is relatively high, with the top 10 representing 64.8% of total assets. The largest sector exposure is Financials at 39.0%.
BOUT sectors provide a detailed breakdown. BOUT overlap shows how holdings compare to other funds in your portfolio.



















